TG-100435
TG-100435 is an investigational oral multi-target tyrosine kinase inhibitor. Its metabolic processing is suppressed by methimazole and ketoconazole, with cytochrome P450 reductase implicated in its formation. This compound is utilized in preclinical research to study kinase signaling pathways in cancer and other diseases, both in cellular and animal models.
Product Specifications
CAS Number
867330-68-5
Field of Research
Cardiovascular Research, Signal Transduction
Smiles
ClC=1C=CC=C (Cl) C1C2=CC=3N=NC (=NC3C (=C2) C) NC4=CC=C (OCCN5CCCC5) C=C4
Molecular Formula
C26H25Cl2N5O
Molecular Weight
494.42
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
